Sequencing
News on NGS technologies, RNA-seq, clinical sequencing, & sample prep in genetics, genomics, and molecular diagnostics.
Adaptive Bio 'Confident' of MRD Reaching Profitability in 2025 as Q4 Revenues Rise 4 Percent
Premium
The Seattle-based firm booked $47.5 million in revenues during the fourth quarter while full-year revenues grew 5 percent to $179.0 million.
GeneDx Shares Climb as Firm Kicks off Epic EHR Integration
After the integration, clinicians can order and send results on all of GeneDx's tests through Epic's Aura electronic health record software.
Oxford Team Debuts Multi-Modal MCED Approach Built on Exact Sciences Methylation Sequencing Tech
Premium
The group's TriOx assay sensitively detected cancers, including at early stages, using combined sequencing of methylation and gene alterations.
Lumea to Incorporate Myriad Genetics Cancer Tests Into Digital Pathology Platform
Under the collaboration, the firms will make Myriad's Prolaris prostate cancer and MyRisk hereditary cancer tests available through Lumea's BxLink digital pathology platform.
Foundation Medicine, Fulgent Genetics Partner to Launch Germline Testing in US
The Foundation Medicine next-generation sequencing-based panels use Fulgent's technology platform and will analyze genes associated with hereditary cancers.